These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Risk of hospitalization for myocardial infarction among users of rofecoxib, celecoxib, and other NSAIDs: a population-based case-control study. Johnsen SP; Larsson H; Tarone RE; McLaughlin JK; Nørgård B; Friis S; Sørensen HT Arch Intern Med; 2005 May; 165(9):978-84. PubMed ID: 15883235 [TBL] [Abstract][Full Text] [Related]
4. Use of first- and second-generation cyclooxygenase-2-selective nonsteroidal antiinflammatory drugs and risk of acute myocardial infarction. Andersohn F; Suissa S; Garbe E Circulation; 2006 Apr; 113(16):1950-7. PubMed ID: 16618816 [TBL] [Abstract][Full Text] [Related]
5. Risk of acute myocardial infarction with nonselective non-steroidal anti-inflammatory drugs: a meta-analysis. Singh G; Wu O; Langhorne P; Madhok R Arthritis Res Ther; 2006; 8(5):R153. PubMed ID: 16995929 [TBL] [Abstract][Full Text] [Related]
6. Antirheumatic drug use and the risk of acute myocardial infarction. Suissa S; Bernatsky S; Hudson M Arthritis Rheum; 2006 Aug; 55(4):531-6. PubMed ID: 16874796 [TBL] [Abstract][Full Text] [Related]
7. The balance between severe cardiovascular and gastrointestinal events among users of selective and non-selective non-steroidal anti-inflammatory drugs. van der Linden MW; van der Bij S; Welsing P; Kuipers EJ; Herings RM Ann Rheum Dis; 2009 May; 68(5):668-73. PubMed ID: 18495734 [TBL] [Abstract][Full Text] [Related]
8. Risk of acute myocardial infarction in patients treated with thiazolidinediones or other antidiabetic medications. Stockl KM; Le L; Zhang S; Harada AS Pharmacoepidemiol Drug Saf; 2009 Feb; 18(2):166-74. PubMed ID: 19109802 [TBL] [Abstract][Full Text] [Related]
9. Cardiovascular events associated with the use of four nonselective NSAIDs (etodolac, nabumetone, ibuprofen, or naproxen) versus a cyclooxygenase-2 inhibitor (celecoxib): a population-based analysis in Taiwanese adults. Huang WF; Hsiao FY; Wen YW; Tsai YW Clin Ther; 2006 Nov; 28(11):1827-36. PubMed ID: 17213003 [TBL] [Abstract][Full Text] [Related]
10. Association between nonnaproxen NSAIDs, COX-2 inhibitors and hospitalization for acute myocardial infarction among the elderly: a retrospective cohort study. Rahme E; Watson DJ; Kong SX; Toubouti Y; LeLorier J Pharmacoepidemiol Drug Saf; 2007 May; 16(5):493-503. PubMed ID: 17086567 [TBL] [Abstract][Full Text] [Related]
11. Cardiovascular outcomes in new users of coxibs and nonsteroidal antiinflammatory drugs: high-risk subgroups and time course of risk. Solomon DH; Avorn J; Stürmer T; Glynn RJ; Mogun H; Schneeweiss S Arthritis Rheum; 2006 May; 54(5):1378-89. PubMed ID: 16645966 [TBL] [Abstract][Full Text] [Related]
12. The use of selective cyclooxygenase-2 inhibitors and the risk of acute myocardial infarction in Saskatchewan, Canada. Varas-Lorenzo C; Castellsague J; Stang MR; Perez-Gutthann S; Aguado J; Rodriguez LA Pharmacoepidemiol Drug Saf; 2009 Nov; 18(11):1016-25. PubMed ID: 19718696 [TBL] [Abstract][Full Text] [Related]
13. Ibuprofen may abrogate the benefits of aspirin when used for secondary prevention of myocardial infarction. Hudson M; Baron M; Rahme E; Pilote L J Rheumatol; 2005 Aug; 32(8):1589-93. PubMed ID: 16078339 [TBL] [Abstract][Full Text] [Related]
14. Gastrointestinal complications of over-the-counter nonsteroidal antiinflammatory drugs. Biskupiak JE; Brixner DI; Howard K; Oderda GM J Pain Palliat Care Pharmacother; 2006; 20(3):7-14. PubMed ID: 16931473 [TBL] [Abstract][Full Text] [Related]
15. Risks and benefits of COX-2 inhibitors vs non-selective NSAIDs: does their cardiovascular risk exceed their gastrointestinal benefit? A retrospective cohort study. Rahme E; Nedjar H Rheumatology (Oxford); 2007 Mar; 46(3):435-8. PubMed ID: 17255138 [TBL] [Abstract][Full Text] [Related]
16. Increased mortality and cardiovascular morbidity associated with use of nonsteroidal anti-inflammatory drugs in chronic heart failure. Gislason GH; Rasmussen JN; Abildstrom SZ; Schramm TK; Hansen ML; Fosbøl EL; Sørensen R; Folke F; Buch P; Gadsbøll N; Rasmussen S; Poulsen HE; Køber L; Madsen M; Torp-Pedersen C Arch Intern Med; 2009 Jan; 169(2):141-9. PubMed ID: 19171810 [TBL] [Abstract][Full Text] [Related]
17. Does the varied use of NSAIDs explain the differences in the risk of myocardial infarction? van Staa TP; Rietbrock S; Setakis E; Leufkens HG J Intern Med; 2008 Nov; 264(5):481-92. PubMed ID: 18624902 [TBL] [Abstract][Full Text] [Related]
18. NSAID use and the risk of hospitalization for first myocardial infarction in the general population: a nationwide case-control study from Finland. Helin-Salmivaara A; Virtanen A; Vesalainen R; Grönroos JM; Klaukka T; Idänpään-Heikkilä JE; Huupponen R Eur Heart J; 2006 Jul; 27(14):1657-63. PubMed ID: 16731535 [TBL] [Abstract][Full Text] [Related]
19. Current use of nonsteroidal antiinflammatory drugs and the risk of acute myocardial infarction. Fischer LM; Schlienger RG; Matter CM; Jick H; Meier CR Pharmacotherapy; 2005 Apr; 25(4):503-10. PubMed ID: 15977911 [TBL] [Abstract][Full Text] [Related]
20. Long-term use of non-steroidal anti-inflammatory drugs and the risk of myocardial infarction in the general population. García Rodríguez LA; González-Pérez A BMC Med; 2005 Nov; 3():17. PubMed ID: 16316472 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]